Control of Resting Heart Rate and Other Risk Factors Over a Three-year Period in Outpatients with Stable Coronary Artery Disease in Latvia

Alberti, K. G., Zimmet, P., Shaw, J. (2005). The metabolic syndrome — a new worldwide definit on. Lancet, 366 (9491), 1059–1062.Search in Google Scholar

Anonīms (2011). Latvijas veselības statistikas gadagrāmata par 2010. gadu [Annual Book of Latvian Health Statistics about 2010]. Rīga: VSMTVA (Veselības statistikas un medicīnas tehnoloìiju valsts aìentûra) (in Latvian).Search in Google Scholar

Anonīms (2013a). Lokren zāïu paraksts. http://www.zva.gov.lv/zalu-registrs/?iss=1&lang=lv&q=Betax&ON=&S N=&NAC=on&RN=&ESC=on&AK=&SAT=on&RA=&DEC=on&LB= &PIM=on (last accessed 20.07.2013).Search in Google Scholar

Anonymous (2013b). Procoralan SPC (Summary of Product Characteristics). http://www.ema.europa.eu/docs/lv_LV/document_library/EPAR_-_Product_Information/human/000597/WC500043590.pdf (last accessed 20.07.2013). Çrglis, A. (2010). Current state of angina treatment in the outpatient population and heart rate monitoring survey in Latvia (REALITY Latvia). Proc. Latvian Acad. Sci. Sect. B, 64 (5/6), 194–201.10.2478/v10046-011-0004-6Search in Google Scholar

Balode, I., Jēgere, S., Mintāle, I., Narbute, I., Zakke, I., Latkovskis, G., Ērglis, A. (2010). Current state of angina treatment in the outpatient population and heart rate monitoring survey in Latvia (REALITY Latvia). Proc. Latvian Acad. Sci. Sect. B, 64 (5/6), 194–201.Search in Google Scholar

Balode, I., Jēgere, S., Mintāle, I., Narbute, I., I., Latkovskis, G., Çrglis, A. (2011) Heart rate and other risk factors in outpatients with stable coronary artery disease in Latvia. Proc. Latvian Acad. Sci. Sect. B, 65 (3/4), 94–101.10.2478/v10046-011-0024-2Search in Google Scholar

Bohm, M., Swedberg, K., Komajda, M., Borer, J., Ford, I., Dubost-Brama, A., Lerebous, G., Tavazzi, L., on behalf of the SHIFT investigators (2010). Heart rate as a risk factor in chronic heart failure (SHIFT): The association between heart rate and outcomes in a randomised placebo-controlled trial. Lancet, 376 (9744), 886–94.Search in Google Scholar

Daly, C. A., De Stavola, B., Lopez-Sendon, J. L., Tavazzi, L, Boersma, E., Clemens, F., Danchin, N., Delahaye, F., Gitt, A., Julian, D., Mulcahy, D., Ruzyllo, W., Thygesen, K., Verheugt, F., Fox K. M. (2006) Predicting prognosis in stable angina — results from the Euro Heart Survey of stable angina: Prospective observational study. BMJ, 332, 262–267.10.1136/bmj.38695.605440.AESearch in Google Scholar

Daly, C., Tavazzi, L., Fox, K., Euro Heart Survey of Angina Investigators (2008). Inadequate control of heart rate in patients with stable angina: Results from the European Heart Survey. Eur. Heart J., 29 (Abstract Supplement), 204.Search in Google Scholar

Diaz, A., Bourassa, M. G., Guertin, M. C., Tardif, J. C. (2005). Long term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur. Heart J., 26 (10), 967–974.10.1093/eurheartj/ehi190Search in Google Scholar

Çrglis, A., Kalvelis, A., Lejnieks, A., Dzērve, V., Latkovskis, G., Mintāle, I., Zakke, I., Rasa, I. (2007). Kardiovaskulāro slimību (KVS) profilakses vadlīnijas [Guidelines on Cardiovascular Disease Prevention]. Rīga: Latvijas Kardiologu biedrība (in Latvian).Search in Google Scholar

Çrglis, A., Jēgere, S., Kalējs, O., Kalvelis, A., Kamzola, G., Lācis, J., Maèa, A., Mintāle, I., Narbute, I., Stradiòð, P., Zakke, I. (2012). Hroniskas sirds mazspējas klīniskās vadlīnijas [Guidelines on Heart Failure Management]. Rīga: Latvijas Kardiologu biedrība (in Latvian).Search in Google Scholar

Fox, K., Garcia, M. A. A., Ardissino, D., Buszman, P., Camici, P. G., Crea, F., Daly, C., Backer, G., Hjemdahl, P., Lopes-Sendon, J., Marco, J., Morais, J., Pepper, J., Sechtem, U., Simoons, M., Thygesen, K. (2006). Guidelines on the management of stable angina pectoris. The Task Force on the Managment of Stable Angina Pectoris of the European Society of Cardiology. Eur. Heart J., 27, 341–1381.Search in Google Scholar

Fox, K., Ford, I., Steg, P. G., Tendera, M., Robertson, M., Ferrari, R., BEAUTIFUL investigators (2008a). Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): A subgroup analysis of a randomised controlled trial. Lancet, 372 (9641), 817–821.Search in Google Scholar

Fox, K., Ford, I., Steg, P. G., Tendera, M., Ferrari, R., BEAUTIFUL investigators (2008b) Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): A randomised, double-blind, placebo-controlled trial. Lancet, 372, 807–816.10.1016/S0140-6736(08)61170-8Search in Google Scholar

Fox, K., Ford, I., Steg, P. G., Tendera, M., Robertson, M., Ferrari, R., BEAUTIFUL investigators (2009). Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease analysis of the randomized, controlled BEAUTIFUL trial. Eur. Heart J., 30, 2337–2345.10.1093/eurheartj/ehp35819720635Search in Google Scholar

Gislason, G. H., Rasmussen, J. N., Abildstrom, S. Z., Gadsboll, N., Buch, P., Friberg, J., Rasmussen, S., Kober, L., Stender, S., Madsen, M., and Torp-Pederden, C. (2006). Long term compliance with beta-blockers, angiotensin-converting inhiitors, and statins after acute myocardial infarction. Eur. Heart Journal, 27, 1153–1158.10.1093/eurheartj/ehi70516399775Search in Google Scholar

Graham, I., Atar, D., Borch-Johnsen, K., Boysen, G., Burell, G., Cifkova, R., Dallongeville, J., De Backer, G., Ebrahim, S., Gjelsvik, B., Herrmann-Lingen, C., Hoes, A., Humphries, S., Knapton, M., Perk, J., Priori, S. G., Pyorala, K., Reiner, Z., Ruilope, L., Sans-Menendez, S., Reimer, V. S. O., Weissberg, P., Wood, D., Yarnell, Y., Zamorano, J. L. (2007). European guidelines on cardiovascular disease prevention in clinical practice: Executive summary. Eur. Heart J., 28, 2375–2414.10.1093/eurheartj/ehm31617726041Search in Google Scholar

Leal, J., Luengo-Fernández, R., Gray, A., Petersen, S., Rayner, M. (2006). Economic burden of cardiovascular diseases in the enlarged European Union. Eur. Heart J., 27 (13), 1610–1619.10.1093/eurheartj/ehi73316495286Search in Google Scholar

Lopez-Sendon, J., Swedberg, K., McMurray J., Tamargo, J., Maggioni, A. P., Dargie, H., Tendera, M., Waagstein, F., Kjekshus, J., Lechat, P., Torp-Pedersen, C. (2004) Expert consensus document on ß-adrenergic receptor blockers. The Task Force on Beta-Blockers of the European Society of Cardiology. Eur. Heart J., 25, 1341–1362.Search in Google Scholar

Mathers, C. D., Loncar, D. (2006). Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med., Nov, 3, e442.10.1371/journal.pmed.0030442166460117132052Search in Google Scholar

McMurray, J. J. V., Adamopoulos, S., Anker, S. D., Auricchio, A., Bohm, M., Dickstein, K., Falk, V., Filippatos, G., Fonseca, C., Gomez-Sanchez, M. A., Jaarsm, T., K¸ber, L., Lip, G. Y. H., Maggioni, A. P., Parkhomenko, A., Pieske, B. M., Popescu, B. A., R¸nnevik, P. K., Rutten, F. H., Schwitter, J., Seferovic, P., Stepinska, J., Trindade, P.T., Voors, A. A., Zannad, F., Zeiher, A. (2012). ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur. Heart J., 33, 1787–1847.10.1093/eurheartj/ehs104Search in Google Scholar

Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Z., Verschuren, W. M. M., Christian Albus, C., Benlian, P., Boysen, G., Cifkova, R., Deaton, C., Ebrahim, S., Fisher, M., Germano, G., Hobbs, R., Hoes, A., Karadeniz, S., Mezzani, A., Prescott, E., Ryden, L., Scherer, M., Syvanne, M., Scholte Op Reimer, W. J. M., Vrints, C., Wood, D., Zamorano, J. S. Zannad, F. (2012). European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). Eur. Heart J., 33, 1635–1701.10.1093/eurheartj/ehs092Search in Google Scholar

Tunstall-Pedoe, H., Kuulasmaa, K., Mähönen, M., Tolonen, H., Ruokokoski, E., Amouyel, P., for the WHO MONICA (monitoring trends and determinants in cardiovascular disease) Project (1999). Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA Project populations. Lancet, 353, 1547–1557.10.1016/S0140-6736(99)04021-0Search in Google Scholar

Swedberg, K., Komajda, M., Bohm, M., Borer, J., Ford, I., Dubost-Brama, A., Lerebous, G., Tavazzi, L., on behalf of the SHIFT investigators (2010). Ivabradine and outcomes in chronic heart failure (SHIFT): A randomised placebo-controlled study. Lancet, 376, 875–885.10.1016/S0140-6736(10)61198-1Search in Google Scholar